In the wild jungle of scientific innovation, Bio Protocol, that quirky DeSci platform, has struck gold-or rather, $6.9 million-from investors like Maelstrom Fund and Animoca Brands. Who said science can’t be a little more “blockchain chic”? 💰💥
Bio Protocol’s mission? To take the snooze-worthy world of biotech research and inject it with a cocktail of AI, blockchain, and crypto. It’s like someone decided to throw a rave in a lab. 🎉🔬
According to Arthur Hayes, founder of Maelstrom, Bio Protocol isn’t just some launchpad for science-oh no, it’s the dawn of a new AI-native research market. If it works. No pressure. 😏
But wait! It gets even juicier. Hayes is raving about how this whole “decentralized” thing means research can finally stop being a snooze fest and become something communities actually care about. Not just the nerdy, white-coated academics. 😜
Of course, CryptoMoon tried reaching out to the titans of Maelstrom and Animoca for more juicy details. But, as is the custom in the glamorous world of DeSci, they didn’t bother to respond. Classic. 🦸♂️
Speeding up science using AI and crypto
So, what exactly is DeSci, you ask? Well, it’s like a rebellious teenager that decided academia needed a little more freedom. Using blockchain, crypto incentives, and decentralized governance, it’s flipping how science gets done. In other words: academia, meet your disruptive cousin, the internet. 🌐🚀
Bio Protocol isn’t wasting time with outdated methods. Forget waiting years for funding or waiting for those pharmaceutical companies to finally decide to play nice. With AI-powered “BioAgents,” researchers can generate hypotheses, connect to wallets (no, not those wallets, sorry), and funnel capital straight into their experiments. Let the money flow! 💸💡
Everything will be recorded on-chain, like the most satisfying form of scientific Instagram-a record of progress that’s totally untouchable. 🙌
But wait! There’s more: Bio Protocol isn’t just a fancy tech toy-it’s got crypto-native incentives that keep the ball rolling. Tokenized intellectual property, staking, and loyalty rewards ensure everyone involved gets their fair share. It’s science meets cryptocurrency, in the most capitalist way possible. 💎🚀
Addressing inefficiencies in academic research
Simon Dedic, the founder of Moonrock Capital, one of Bio Protocol’s investors, dropped a truth bomb: DeSci might seem like a meme at first. But don’t be fooled, folks-this project is going to make science great again (and possibly slightly less pretentious). 🎩✨
Having spent his own life trapped in the chains of academic science, Dedic is a true insider. He knows how broken the system is, with its misaligned incentives and embarrassing consequences. “Bio Protocol,” he says, “is the hero we didn’t deserve but desperately need.” 🦸♂️
In the grand scheme, Bio Protocol’s work is part of a larger DeSci movement, attempting to free science from the shackles of universities, government grants, and pharma companies. In short, it’s science for the people! 📚💪
Read More
- Deadlock The Doorman Guide: Big Tips & Tricks
- Kunitsu-Gami: Path of the Goddess ‘Mazo Talisman: Yashichi Waves’ update launches in July
- Steam RPG From 2023 Being Removed Next Month and PC Users Aren’t Happy: “Huge Potential Wasted”
- Gears of War: Reloaded is Now Available
- Yakuza Maker’s Next PS5 Game Gets a Brief Behind-the-Scenes Video
- ‘My Name Is Jeff’: Channing Tatum Played Another Jeff In Roofman, And Is Considering Legally Changing His Name
- Alabaster Dawn Demo is Now Available on PC
- ‘LEGO Batman: Legacy of the Dark Knight’ Reveals Its 7 Main Batsuits
- Preview: Teamwork Is the True Terror of Little Nightmares 3
- No Upgrade Path for the Belated PS5 Version of Yakuza 0 Director’s Cut
2025-09-18 13:51